Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus
Status:
Terminated
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This research study involves an experimental drug (NST_001) and a delivery system. The main
purpose of this research study is to investigate the safety of NST-001, delivered directly to
the inner ear for the treatment of tinnitus.